The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
In: Breast cancer research and treatment, Jg. 204 (2024), Heft 2, S. 299-308
Online
academicJournal
Zugriff:
Titel: |
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
|
---|---|
Autor/in / Beteiligte Person: | Zhu, YJ ; Zerdes, I ; Matikas, A ; Cruz, IR ; Bergqvist, M ; Elinder, E ; Bosch, A ; Lindman, H ; Einbeigi, Z ; Andersson, A ; Carlsson, L ; Dreifaldt, AC ; Isaksson-Friman, E ; Hellstrom, M ; Johansson, H ; Wang, K ; Bergh, JCS ; Hatschek, T ; Foukakis, T |
Link: | |
Zeitschrift: | Breast cancer research and treatment, Jg. 204 (2024), Heft 2, S. 299-308 |
Veröffentlichung: | 2024 |
Medientyp: | academicJournal |
ISSN: | 1573-7217 (print) |
DOI: | 10.1007/s10549-023-07200-x |
Schlagwort: |
|
Sonstiges: |
|